Literature DB >> 11437926

A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients.

V E Von Gruenigen1, L J White, M S Kirven, A L Showalter, M P Hopkins, E L Jenison.   

Abstract

Our objective was to describe and compare the use of complementary and alternative medicine (CAM) in gynecology and gynecological oncology patients. Five hundred and twenty-nine gynecology and gynecological oncology patients completed a questionnaire regarding CAM use. Overall, 56.3% of gynecology and gynecological oncology patients reported current use of CAM. Therapies used included nutritional supplements (20%), prayer as medical therapy (17%), exercise as medical therapy (12%), megavitamins (10%), and green tea (10%). While 69.5% believed CAM to be beneficial, only 31.6% discussed these therapies with their physician. The women spent a mean of $656.22 on CAM (range $0-$7,000), with 31.7% receiving some insurance reimbursement. Gynecologic oncology patients (n = 161) used CAM significantly more than gynecology patients (n = 368) (66% vs. 52%, 95% CI = 0.046-0.230, P = 0.004). Gynecological oncology patients also spent more for CAM, with a mean expenditure of $711 versus $622 by gynecology patients. Within the gynecological oncology patient group, there were 69 patients currently receiving modern medical treatments for cancer; among these patients, 58% reported using CAM; of these, 39.3% communicated their use of CAM to their physician. Patients in this group spent an average of $1,178 on CAM during their illness, with only 6.3% receiving insurance reimbursement. Benefits from CAM were perceived by 54.5% in this group. We concluded that cancer patients have a higher usage rate and expenditure for CAM, particularly while they are receiving medical therapy, and are more likely to discuss the use of alternative therapies with their physicians. CAM was perceived as helpful by patients despite the lack of scientific data about its effect.

Entities:  

Mesh:

Year:  2001        PMID: 11437926     DOI: 10.1046/j.1525-1438.2001.01011.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  14 in total

1.  Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations.

Authors:  Marion M Lee; Jeffrey S Chang; Bradly Jacobs; Margaret R Wrensch
Journal:  Am J Public Health       Date:  2002-10       Impact factor: 9.308

Review 2.  Adverse events associated with complementary and alternative medicine use in ovarian cancer patients.

Authors:  Erin S Sweet; Leanna J Standish; Barbara A Goff; M Robyn Andersen
Journal:  Integr Cancer Ther       Date:  2013-04-26       Impact factor: 3.279

3.  Complementary and alternative medicine (CAM) use in women with pelvic floor disorders: a cohort study.

Authors:  Shannon L Slavin; Rebecca G Rogers; Yuko Komesu; Tola Omotosho; Sarah Hammil; Cindi Lewis; Robert Sapien
Journal:  Int Urogynecol J       Date:  2009-12-05       Impact factor: 2.894

Review 4.  Effective communication about the use of complementary and integrative medicine in cancer care.

Authors:  Moshe Frenkel; Lorenzo Cohen
Journal:  J Altern Complement Med       Date:  2013-07-17       Impact factor: 2.579

5.  Discrepant views of oncologists and cancer patients on complementary/alternative medicine.

Authors:  Mary Ann Richardson; Louise C Mâsse; Kelly Nanny; Christina Sanders
Journal:  Support Care Cancer       Date:  2004-11       Impact factor: 3.603

6.  Teaching complementary medicine at an academic oncology department.

Authors:  Eran Ben-Arye; Moshe Frenkel; Gil Bar-Sela; Ruth Stashefsky Margalit; Doron Hermoni; Abraham Kuten
Journal:  J Cancer Educ       Date:  2008 Jan-Mar       Impact factor: 2.037

7.  Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study.

Authors:  Thomas M Habermann; Carrie A Thompson; Betsy R LaPlant; Brent A Bauer; Carol A Janney; Matthew M Clark; Teresa A Rummans; Matthew J Maurer; Jeff A Sloan; Susan M Geyer; James R Cerhan
Journal:  Am J Hematol       Date:  2009-12       Impact factor: 10.047

Review 8.  A Review of Integrative Medicine in Gynaecological Oncology.

Authors:  M Kalder; T Müller; D Fischer; A Müller; W Bader; M W Beckmann; C Brucker; C C Hack; V Hanf; A Hasenburg; A Hein; S Jud; M Kiechle; E Klein; D Paepke; A Rotmann; F Schütz; G Dobos; P Voiß; S Kümmel
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-02       Impact factor: 2.915

9.  A narrative review of medical, chiropractic, and alternative health practices in the treatment of primary dysmenorrhea.

Authors:  Lolita G Spears
Journal:  J Chiropr Med       Date:  2005

10.  The use of dietary supplements in oncology.

Authors:  Moshe Frenkel; Victor Sierpina
Journal:  Curr Oncol Rep       Date:  2014-11       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.